The 2024 World Conference on Lung Cancer may still be months away, but with deadlines approaching, now is the time to submit scientific abstracts and applications for the JTO manuscript reviewer workshop. Read more
Research teams with integrated projects focused on curing oncogene-driven lung cancers could receive up to $2.5 million over 4 years. Read more
As the IASLC celebrates its 50th year, the association’s journal moves to online only and the American Cancer Society recommends expanding screening eligibility. Read more
The initiatives include a $2.5 million, 4-year research grant and projects to improve lung cancer biomarker testing uptake around the world. Read more
The association recommends collecting data on tobacco use status to advance knowledge on the impacts of tobacco smoke in the context of cancer clinical trials. Read more
Dr. Jennifer King brings expertise in molecular targets for cancer therapeutics as well as executive-level experience implementing strategic initiatives to the scientific affairs team. Read more
Editor-in-Chief Dr. Alex Adjei announced the journal’s impact factor once again rose in 2022 and says it remains the leading journal in thoracic oncology. Read more
The newly elected board members, including President-Elect Dr. Caicun Zhou, will assume their roles at the upcoming 2023 World Conference on Lung Cancer in Singapore. Read more
IASLC Pathology Committee members say the identification and evaluation of features that result in discordance in measuring invasive tumor size will hopefully improve reproducibility and lead to more accurate tumor staging moving forward. Read more
In a recent interview, Staging and Prognostic Factors Committee Chair Dr. Hisao Asamura provides an update on efforts to further refine the system. Read more